Shmulik earned his Ph.D here at the Weizmann Institute under the mentorship of Prof. Alexander Tsafriri in the department of Biological Regulation, followed by a postdoc fellowship at Massachusetts Institute of Technology with Prof. Ernest Fraenkel in the dept. of Biological Engineering. His research there focused on transcriptional regulation of type II diabetes mellitus. Before joining the G-INCPM, Shmulik managed the Genomics wet lab at the BioMicro Center – The MIT Genomics core facility.
Shlomit earned her Ph.D. in human genetics from Tel-Aviv University. Prior to joining the Center, Shlomit worked for 15 years at the Israeli companies QBI and Rosetta Genomics. During this period Shlomit co-developed diagnostic assays from the initial idea to market. She has many years of experience in developing novel molecular biology protocols and managing R&D teams. Shlomit is an expert in many molecular biology techniques and has seven US patents for novel methods and compositions and 34 peer reviewed publications. Shlomit Joined the Center in September, 2012, as Head of R&D and was recently promoted to Platform Head.